Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Adverum Biotechnologies Inc. sell klostergang

Adverum Biotechnologies Inc.
Start price
€2.62
02.11.18 / 50%
Target price
€2.16
02.01.19
Performance (%)
8.62%
End price
€2.84
02.01.19
Summary
This prediction ended on 02.01.19 with a price of €2.84. With a performance of 8.62%, the SELL prediction by klostergang for Adverum Biotechnologies Inc. was trending in the wrong direction klostergang has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Adverum Biotechnologies Inc. - - - -
iShares Core DAX® -0.046% 5.960% 7.403% 65.851%
iShares Nasdaq 100 0.922% 3.693% 28.138% 93.298%
iShares Nikkei 225® 3.014% 6.638% 48.886% 89.079%
iShares S&P 500 -0.359% 2.747% 22.530% 71.942%

Comments by klostergang for this prediction

In the thread Adverum Biotechnologies Inc. diskutieren
Prediction Sell
Perf. (%) 8.62%
Target price 2.165
Change
Ends at 02.01.19

Avalanche down on data from its ADVANCE Phase 1/2 study


Adverum after a program update says it's going to end development of its gene therapy for A1AT deficiency.



klostergang 
0
Report Share
02.11.18
Prediction Sell
Perf. (%) 8.62%
Target price 2.165
Change
Ends at 02.01.19

(Laufzeit überschritten)

klostergang 
0
Report Share
02.01.19